December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Olubukola Ayodele: Had an incredible experience at the San Antonio Breast Cancer Symposium 2024!
Dec 15, 2024, 09:27

Olubukola Ayodele: Had an incredible experience at the San Antonio Breast Cancer Symposium 2024!

Olubukola Ayodele shared on LinkedIn:

“I’ve had an incredible experience at the San Antonio Breast Cancer Symposium 2024! As my first time attending this prestigious event, it has truly been a week packed with activities and learning opportunities.

This year, I had the honour of presenting two poster sessions as the senior author, which allowed me to share my research with an enthusiastic audience.

The insights gained from the different discussions and presentations were invaluable, broadening my understanding of the latest advancements in breast cancer research.

A highlight of my time here was reuniting with my mentors, Philippe Bedard and David Cescon, along with many other esteemed colleagues such as Dario Trapani, Tira Tan and Yada Kanjanapan. It was inspiring to connect with such brilliant minds in the field and share our experiences.

I am excited about the potential collaborations that will emerge from the networking opportunities at SABCS 2024. I’m filled with vigor to do more in the breast cancer space.

Thank you, San Antonio, for hosting an exceptional conference. It has been a successful and enriching experience, and I can’t wait to return for the next one!”

Olubukola Ayodele: Had an incredible experience at the San Antonio Breast Cancer Symposium 2024!

Dr. Olubukola Ayodele is a Consultant Medical Oncologist at the University Hospitals of Leicester NHS Trust, specializing in breast and genitourinary malignancies, including germ cell tumors. She is also an honorary Senior Lecturer at the University of Leicester and heads the Breast Cancer Clinical Trials Unit at the Leicester Cancer Research Centre.

Dr. Ayodele’s work includes numerous publications, clinical trials, and collaborative research projects on molecular drivers and biomarkers in breast cancer. She is a member of ASCO, ESMO, ACP and UKBCG.